Anagen effluvium: Difference between revisions
Appearance
Content deleted Content added
box, nav |
No edit summary |
||
Line 13: | Line 13: | ||
| MeshID = |
| MeshID = |
||
}} |
}} |
||
'''Anagen effluvium''' is the pathologic loss of anagen hairs |
'''Anagen effluvium''' is the pathologic loss of anagen or growth-phase hairs. It is classically caused by radiation therapy to the head and systemic chemotherapy, especially with alkylating agents.<ref name="Fitz2">Freedberg, et al. (2003). ''Fitzpatrick's Dermatology in General Medicine''. (6th ed.). Page 640. McGraw-Hill. ISBN 0071380760.</ref><ref name="Andrews">James, William; Berger, Timothy; Elston, Dirk (2005). ''Andrews' Diseases of the Skin: Clinical Dermatology''. (10th ed.). Saunders. ISBN 0721629210.</ref>{{rp|753-4}} |
||
==See also== |
==See also== |
Revision as of 22:16, 31 January 2011
Anagen effluvium | |
---|---|
Specialty | Dermatology |
Anagen effluvium is the pathologic loss of anagen or growth-phase hairs. It is classically caused by radiation therapy to the head and systemic chemotherapy, especially with alkylating agents.[1][2]: 753–4
See also
References